Epigenetics Market Size & Share, by Product (Kits, Reagents, Enzymes, Instruments); Application (Oncology, Autoimmune Diseases, Metabolic Diseases, CNS/Pain Diseases, Cardiovascular Diseases); End-user (Academic, Research Institutes, Pharmaceutical, Biotechnology Companies, Contract Research Organizations); Technology (Methylation, Acetylation, Phosphorylation) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4874
  • Published Date: Apr 30, 2023
  • Report Format: PDF, PPT

Companies Dominating the Epigenetics Landscape

    • Abcam PLC
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Diagenode Inc.
    • Merck KGaA
    • Element Biosciences, Inc.
    • PacBio
    • Active Motiff
    • Illumina Inc.
    • Agilent Technologies, Inc.
    • Bio-Rad Laboratories, Inc.
    • EpiGentek Group Inc.

Browse Key Market Insights with Data Illustration:


In The News

  • In partnership with Dovetail Genomics, the developer of a new and disruptive DNA sequencing platform, Element Biosciences Inc. A demonstration of Dovetail's proximity ligation-based library preparation solutions for next-generation sequencing will be conducted on the AVITI System of Element Biosciences.
  • A leading developer of high-quality, highly accurate sequencing solutions, PacBio, has introduced its Sequel IIe and Sequel II systems with a new capability to detect DNA methylation. These new systems have the ability to identify specific regions of the genome that have been altered by methylation, which is a type of chemical modification to DNA that can influence gene expression.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 4874
  • Published Date: Apr 30, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing prevalence of lifestyle-related chronic diseases such as cancer, diabetes, and cardiovascular diseases, and increasing research activities in the field of epigenetics are the major factors driving the market growth.

The market size of epigenetics is anticipated to attain a CAGR of ~17% over the forecast period, i.e., 2023-2035.

High cost associated with epigenetics services and the lack of skilled professionals to interpret the results of epigenetics tests are estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Abcam PLC, Diagenode Inc., Merck KGaA, Element Biosciences, Inc., PacBio, Active Motiff, Illumina Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., EpiGentek Group Inc., and others.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product, application, end user, technology and by region.

The kits and reagents segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying